Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.

@article{Jick2006RiskON,
  title={Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.},
  author={Susan Sara Jick and James A. Kaye and Stefan Russmann and Hershel Jick},
  journal={Contraception},
  year={2006},
  volume={73 3},
  pages={223-8}
}
CONTEXT There is concern that a new transdermal contraceptive patch containing ethinyl estradiol (EE) and the progestin norelgestromin increases the risk for venous thromboembolism (VTE) compared to previously marketed oral contraceptives (OCs). OBJECTIVE Quantitative information was obtained on the risk of nonfatal VTE in women using the contraceptive… CONTINUE READING